A detailed history of Annex Advisory Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Annex Advisory Services, LLC holds 4,833 shares of NVO stock, worth $423,612. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,833
Previous 8,983 46.2%
Holding current value
$423,612
Previous $1.28 Million 55.15%
% of portfolio
0.02%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$119.07 - $145.42 $494,140 - $603,493
-4,150 Reduced 46.2%
4,833 $575,000
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $11,289 - $13,515
92 Added 1.03%
8,983 $1.28 Million
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $907,860 - $1.21 Million
8,891 New
8,891 $1.14 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Annex Advisory Services, LLC Portfolio

Follow Annex Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.